Skip to main content

Articles By Jack Cush, MD

bone%20dense.jpg (keep)

Anti-Sclerostin Drug Hampered by Heart Problems

Reuters reports that FDA approval of romosozumab (brand name Evenity) may be held up because of higher rates of cardiac events seen in a late-stage clinical trial.

Read Article
WIR.large_.jpg (keep)

The RheumNow Week in Review – 17 May 2017

Dr. Jack Cush reviews highlights and updates from the past week on RheumNow.com:

Read Article
CTRL_0.jpg

My Approach to Difficult RA

Patients are labeled as having “difficult RA" when: 1) we are frustrated, 2) it's too late, 3) we've run out of options or 4) the relationship is failing. We see them, but don’t quite know what to do with them.

Read Article
narcotic%20pills.jpg

Non-Prescribed Opioid Abuse by Young Adults

Journal of Addiction Medicine reported that young adults often are "self-medicated" to manage pain.

Read Article
t22t.jpg

Educational Intervention Facilitates Treat-to-Target Management in Rheumatoid Arthritis

Treat-to-target education through group-based quality improvement sessions can result in wider use of treat-to-target in practice, according to researchers.

Read Article
biosimilars2.jpg

NOR-SWITCH Study Validates Biosimilar Use in Multiple Indications

Lancet reports the results of the NOR-SWITCH study - a trial performed in Norway as biosimilars were being introduced.

Read Article
knee.injx_.ant_.jpg

Steroid Injections for Knee Osteoarthritis May Promote Cartilage Loss

Treatment of knee osteoarthritis (with synovitis) with an injection of a corticosteroid every three months over two years resulted in significantly greater cartilage volume loss and no significant difference in knee pain compared to patients who received a placebo injection, according to a study

Read Article
Knee.arthroscopic.jpg

No Arthroscopy Needed for Degenerative Knees and Meniscal Tears

The British Medical Journal has published a clinical practice guideline for the use of arthroscopic surgery for degenerative knee arthritis and meniscal tears, suggesting that many patients will not benefit from such surgery.

Read Article
IPF.lancet.jpg

Rituximab May Benefit Rheumatoid Lung

A retrospective study shows that rituximab treatment of RA-related interstitial lung disease may improve or forestall ILD progression.

Read Article
WIR.large_.jpg (keep)

The RheumNow Week in Review – 12 May 2017

Dr. Jack Cush highlights the big stories, news and articles from this week at RheumNow.com.

Read Article
×